too , LTTS has a role to play in supporting healthcare providers .
“ If there is one positive outcome of this life-changing event , it is the massively increased adoption of telehealth and remote care solutions ,” he says . “ If we were to rewind the last six months , some of the major issues standing in the way of greater adoption of telehealth were regulatory approvals for most of the procedures , insurance reimbursements for telehealth-based treatments , and security concerns .
“ Now , as a result of Covid-19 , regulations have been eased by CDC and HHS for more than 80 telehealth-based procedures . CMS has approved them for Medicare , and other insurance companies have agreed for reimbursements . As a result , providers have rolled them out in greater numbers . Patients have adopted them like never before : in some of the larger health systems , telehealth transactions have gone from a few thousand per month to tens of thousands per week .”
115
EXECUTIVE PROFILE :
Jyotirmay Datta Title : EVP and CBO Industry : Healthcare
Company : L & T Technology Services
Jyotirmay Datta ( JD ) is the EVP and CBO - Healthcare at L & T Technology Services and heads the Medical Devices Business with P & L responsibility for LTTS ’ businesses across Med-Tech , Lifesciences and Healthcare customers . With 30 years of experience in the Technology and Healthcare industries , JD specialize in shaping , nurturing and leading businesses that serve the needs of Med-Tech & Lifesciences companies and Healthcare providers in improving access , efficacy and outcome of Connected Care across the care pathway . healthcareglobal . com